 |
|
|
| |
- The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer
Vaccine, Vol. 23, No. 17-18, Mar 2005, pp. 2374-2378
- Migration of dendritic cell based cancer vaccines: in vivo veritas?
Current opinion in immunology, Vol. 17, No. 2, Apr 2005, pp. 170-174
- Regulators of Apoptosis: Suitable Targets for Immune Therapy of Cancer
Nature Reviews: Drug Discovery, Vol. 4, No. 5, May 2005, pp. 399-409
- Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2
Clinical Immunology, Vol. 114, No. 1, Jan 2005, pp. 70-78
- Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment
FEMS microbiology letters, Vol. 246, No. 1, 1 May 2005, pp. 67-73
- Identification of Noncanonical Melanoma-Associated T Cell Epitopes for Cancer Immunotherapy
Journal of Immunology, Vol. 174, No. 11, 1 Jun 2005, pp. 6716-6724
- Altered intracellular sorting signals do not influence the efficacy of genetic melanoma vaccines incorporating helper determinants in mice
Journal of Gene Medicine, Vol. 7, No. 5, May 2005, pp. 613-620
- Electroporation as a "Prime/Boost" Strategy for Naked DNA Vaccination against a Tumor Antigen
Journal of Immunology, Vol. 174, No. 10, May 2005, pp. 6292-6298
- Exosomes: A new delivery system for tumor antigens in cancer immunotherapy
International Journal of Cancer, Vol. 114, No. 4, 2005, pp. 613-622
- Immune-Reconstituted Influenza Virosome Containing CD40L Gene Enhances the Immunological and Protective Activity of a Carcinoembryonic Antigen Anticancer Vaccine
Journal of Immunology, Vol. 174, No. 11, 1 Jun 2005, pp. 7210-7216
- Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
Proceedings of the National Academy of Sciences, USA, Vol. 102, No. 11, 15 Mar 2005, pp. 4185-4190
- Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome
Journal of Immunology, Vol. 174, No. 4, 15 Feb 2005, pp. 1811-1819
- A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour
Cancer Immunology, Immunotherapy, Vol. 54, No. 2, Feb 2005, pp. 157-171
- DNA Vaccines: Progress and Challenges
Journal of Immunology, Vol. 175, No. 2, Jul 2005, pp. 633-639
- IL-4-Transfected Tumor Cell Vaccines Activate Tumor-Infiltrating Dendritic Cells and Promote Type-1 Immunity
Journal of Immunology, Vol. 174, No. 11, 1 Jun 2005, pp. 7194-7201
- CD4 T cells in tumor immunity
Springer seminars in immunopathology, Vol. 27, No. 1, Jun 2005, pp. 37-48
- Gene Therapy to Manipulate Effector T Cell Trafficking to Tumors for Immunotherapy
Journal of Immunology, Vol. 174, No. 9, 1 May 2005, pp. 5766-5773
- T-cell triggering by CD3-and CD28-binding molecules linked to a human virus-modified tumor cell vaccine
Vaccine, Vol. 23, No. 19, Mar 2005, pp. 2439-2453
- Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo
Nature medicine, Vol. 11, No. 2, 2005, pp. 130-137
- Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo
Nature medicine, Vol. 11, No. 2, Feb 2005, pp. 130-137
- Cancer vaccines and immunotherapies: emerging perspectives
Vaccine, Vol. 23, No. 17-18, Mar 2005, pp. 2359-2362
- Preclinical evaluation of autologous dendritic cells transfected with mRNA or loaded with apoptotic cells for immunotherapy of high-risk neuroblastoma
Cancer gene therapy, Vol. 12, No. 8, Aug 2005, pp. 699-707
- Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn
Cancer Immunology, Immunotherapy, Vol. 54, No. 5, May 2005, pp. 424-430
- Modification of Professional Antigen-Presenting Cells with Small Interfering RNA In vivo to Enhance Cancer Vaccine Potency
Cancer research, Vol. 65, No. 1, Jan 2005, pp. 309-316
- Rapid Assessment of Recognition Efficiency and Functional Capacity of Antigen-Specific T-Cell Responses
Journal of Immunotherapy, Vol. 28, No. 4, Jul-Aug 2005, pp. 297-305
- Immunotherapy for Pancreatic Cancer : Science Driving Clinical Progress
Nature Reviews: Cancer, Vol. 5, No. 6, Jun 2005, pp. 459-467
- Surrogate Tumor Antigen Vaccination Induces Tumor-Specific Immunity and the Rejection of Spontaneous Metastases
Cancer research, Vol. 65, No. 7, 1 Apr 2005, pp. 2938-2946
- Recombinant NY-ESO-1 Cancer Antigen: Production and Purification under cGMP Conditions
Preparative Biochemistry and Biotechnology, Vol. 35, No. 2, 2005, pp. 119-134
- CpG Oligonucleotide Therapy Cures Subcutaneous and Orthotopic Tumors and Evokes Protective Immunity in Murine Bladder Cancer
Journal of Immunotherapy, Vol. 28, No. 1, Jan 2005, pp. 20-27
- Breaking tolerance in cancer immunotherapy: time to ACT
Current opinion in immunology, Vol. 17, No. 2, Apr 2005, pp. 187-194
- Measuring Melanoma-Specific Cytotoxic T Lymphocytes Elicited by Dendritic Cell Vaccines with a Tumor Inhibition Assay In Vitro
Journal of Immunotherapy, Vol. 28, No. 2, Mar 2005, pp. 148-157
- Targeted Delivery of the ErbB2/HER2 Tumor Antigen to Professional APCs Results in Effective Antitumor Immunity
Journal of Immunology, Vol. 174, No. 9, 1 May 2005, pp. 5481-5489
- Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct
British journal of cancer, Vol. 92, No. 8, 25 Apr 2005, pp. 1421-1429
- Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence
International Journal of Cancer, Vol. 113, No. 2, 20 Jan 2005, pp. 259-266
- Linked Foreign T-Cell Help Activates Self-Reactive CTL and Inhibits Tumor Growth
Journal of Immunology, Vol. 175, No. 1, 1 Jul 2005, pp. 329-334
- Anti-angiogenic therapy subsequent to adeno-associated-virus-mediated immunotherapy eradicates lymphomas that disseminate to the liver
International Journal of Cancer, Vol. 113, No. 4, 2005, pp. 670-677
- Modulation of antitumor responses by dendritic cells
Springer seminars in immunopathology, Vol. 26, No. 3, Jan 2005, pp. 329-341
- Vaccination of Apoptotic Fas Ligand-expressing Tumors Decreased Antitumor Responses by Enhanced Production of Immunosuppressive Cytokines
Anticancer Research, Vol. 25, No. 1A, Jan-Feb 2005, pp. 299-304
- Understanding the response to immunotherapy in humans
Springer seminars in immunopathology, Vol. 27, No. 1, Jun 2005, pp. 105-117
- Hsp70-Like Protein 1 Fusion Protein Enhances Induction of Carcinoembryonic Antigen-Specific CD8 super(+) CTL Response by Dendritic Cell Vaccine
Cancer research, Vol. 65, No. 11, 1 Jun 2005, pp. 4947-4954
- MUC1 Peptide Vaccination in Patients with Advanced Pancreas or Biliary Tract Cancer
Anticancer Research, Vol. 25, No. 5, Sep-Oct 2005, pp. 3575-3580
- Diverse CD8 super(+) T-Cell Responses to Renal Cell Carcinoma Antigens in Patients Treated with an Autologous Granulocyte-Macrophage Colony-Stimulating Factor Gene-Transduced Renal Tumor Cell Vaccine
Cancer research, Vol. 65, No. 3, 1 Feb 2005, pp. 1079-1088
|
|
 |
|
 |
|
|
